{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:17:17Z","timestamp":1697397437594},"reference-count":8,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,1,15]]},"DOI":"10.1182\/blood-2002-09-2769","type":"journal-article","created":{"date-parts":[[2002,12,31]],"date-time":"2002-12-31T00:55:15Z","timestamp":1041296115000},"page":"781-781","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy"],"prefix":"10.1182","volume":"101","author":[{"given":"Stuart L.","family":"Goldberg","sequence":"first","affiliation":[{"name":"Correspondence: Stuart L. Goldberg, The Cancer Center at Hackensack University Medical Center, 20 Prospect Ave, Suite 400, Hackensack, NJ 07601; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi A.","family":"Madan","sequence":"additional","affiliation":[{"name":"Correspondence: Stuart L. Goldberg, The Cancer Center at Hackensack University Medical Center, 20 Prospect Ave, Suite 400, Hackensack, NJ 07601; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Rowley","sequence":"additional","affiliation":[{"name":"Correspondence: Stuart L. Goldberg, The Cancer Center at Hackensack University Medical Center, 20 Prospect Ave, Suite 400, Hackensack, NJ 07601; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Pecora","sequence":"additional","affiliation":[{"name":"Correspondence: Stuart L. Goldberg, The Cancer Center at Hackensack University Medical Center, 20 Prospect Ave, Suite 400, Hackensack, NJ 07601; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack W.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Correspondence: Stuart L. Goldberg, The Cancer Center at Hackensack University Medical Center, 20 Prospect Ave, Suite 400, Hackensack, NJ 07601; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramana","family":"Tantravahi","sequence":"additional","affiliation":[{"name":"Correspondence: Stuart L. Goldberg, The Cancer Center at Hackensack University Medical Center, 20 Prospect Ave, Suite 400, Hackensack, NJ 07601; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111821401820400_B1","first-page":"1a","article-title":"STI571 (Gleevec\/Glivec, imatinib) versus interferon + cytarabine as initial therapy for patients with CML: results of a randomized study [abstract].","volume":"21","author":"Druker","year":"2002","journal-title":"Proc Am Soc Clin Oncol."},{"key":"2019111821401820400_B2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7326\/0003-4819-122-4-199502150-00003","article-title":"Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon therapy.","volume":"122","author":"Kantarjian","year":"1995","journal-title":"Ann Intern Med."},{"key":"2019111821401820400_B3","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V91.9.3357","article-title":"Highly sensitive fluorescence in situ hybridization method to detect double BCR\/ABL fusion and monitor response to therapy in chronic myeloid leukemia.","volume":"91","author":"DeWald","year":"1998","journal-title":"Blood."},{"key":"2019111821401820400_B4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1200\/JCO.2000.18.7.1533","article-title":"Fluorescence in situ hybridization on peripheral blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia.","volume":"18","author":"LeGouill","year":"2000","journal-title":"J Clin Oncol."},{"key":"2019111821401820400_B5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V100.2.435","article-title":"Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience.","volume":"100","author":"Braziel","year":"2002","journal-title":"Blood."},{"key":"2019111821401820400_B6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0145-2126(01)00140-0","article-title":"Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient with hydroxyurea.","volume":"26","author":"Flamm","year":"2002","journal-title":"Leuk Res."},{"key":"2019111821401820400_B7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0165-4608(94)00197-9","article-title":"Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia.","volume":"81","author":"Ariyama","year":"1995","journal-title":"Cancer Genet Cytogenet."},{"key":"2019111821401820400_B8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2400642","article-title":"Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases.","volume":"11","author":"Fayad","year":"1997","journal-title":"Leukemia."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/2\/781\/1261427\/h80203000779b.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/2\/781\/1261427\/h80203000779b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:40:32Z","timestamp":1574131232000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/2\/781\/106480\/Myelodysplastic-subclones-in-chronic-myeloid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,15]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-09-2769","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1,15]]}}}